TransCelerate membership is available to pharmaceutical/biopharmaceutical companies with R&D organizations who engage in innovative discovery, development, and manufacturing of new drugs. Membership is limited to companies; we do not offer membership to individuals. Our Members
Explore
Featured Solution: Comparator Network As part of the close-out of activities for a Phase III trial, we managed to donate to a patient in Ukraine that was under standard of care treatment that could no longer be supplied under study sponsor responsibility, a batch of all our remaining and compliant treatment. This supported the patient…
Explore
TransCelerate’s efforts have had a transformative impact on the entire R&D ecosystem. Visit our library of Solution Implementation Experiences. Since 2012, TransCelerate has designed, developed, and delivered 525+ solutions and implementation tools1. Most of these are free for public download and use. 1 – Numbers based on data from 2022 TransCelerate portfolio delivery Solution Implementation Experiences TransCelerate…
Explore
Blog December 2, 2020
This is the first article in a five-part blog series about TransCelerate’s data sharing initiatives. This first piece will explore the foundations of our data sharing work. Future topics in this series will include our work on data sharing to support a robust response to COVID-19, patient privacy, and toxicology, among others. TransCelerate BioPharma was…
Explore
Blog October 20, 2022
2022 marks the Tenth Anniversary of TransCelerate. 150 current and past members, contributors, and other industry stakeholders from around the world convened at the Franklin Institute in Philadelphia on October 6, 2022, to celebrate. At its founding, TransCelerate’s goal was to tackle five persistent issues in clinical trials: development of a shared user interface for…
Explore
Overview TransCelerate held its first annual Realization Summit which provided attendees with an opportunity to learn about initiative solutions and delivery, engage in one-on-one conversations with initiative experts, as well as discussions with industry representatives from the entire clinical trial ecosystem. Three Tracks The two-day event featured dedicated time to visit interactive learning tables hosted…
Explore
TransCelerate remains convinced that the only way these challenging problems can be addressed is through collaboration. Since launching in 2012, TransCelerate has invested in simplifying and accelerating the research and development of innovative new therapies. Through tackling initiatives such as Risk Based Monitoring, Site Qualification & Training, and the Comparator Network, we are building the bridge to…
Explore
Overview TransCelerate held its most widely attended Realization Summit to date! The event welcomed more than 500 attendees representing more than 25 countries and 19 Member Companies. The two-day event offered all attendees, virtual and in-person, the opportunity to directly connect with initiative experts, senior industry representatives and colleagues across all levels of the research…
Explore
Initiative
Explore
Explore
